CR10038A - Analogo de la diazonamida a - Google Patents

Analogo de la diazonamida a

Info

Publication number
CR10038A
CR10038A CR10038A CR10038A CR10038A CR 10038 A CR10038 A CR 10038A CR 10038 A CR10038 A CR 10038A CR 10038 A CR10038 A CR 10038A CR 10038 A CR10038 A CR 10038A
Authority
CR
Costa Rica
Prior art keywords
diazonamide
analog
conjugates
salts
effective
Prior art date
Application number
CR10038A
Other languages
English (en)
Spanish (es)
Inventor
Harran Patrick
Williams Noelle
Burgett Anthony
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/264,502 external-priority patent/US7517895B2/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of CR10038A publication Critical patent/CR10038A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR10038A 2005-10-31 2008-05-30 Analogo de la diazonamida a CR10038A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/264,502 US7517895B2 (en) 2001-08-24 2005-10-31 Synthetic diazonamides
US81465106P 2006-06-16 2006-06-16

Publications (1)

Publication Number Publication Date
CR10038A true CR10038A (es) 2008-09-12

Family

ID=38006479

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10038A CR10038A (es) 2005-10-31 2008-05-30 Analogo de la diazonamida a

Country Status (8)

Country Link
US (1) US7538129B2 (enExample)
EP (1) EP1948169A4 (enExample)
JP (1) JP2009513710A (enExample)
AU (1) AU2006308849A1 (enExample)
BR (1) BRPI0618136A2 (enExample)
CR (1) CR10038A (enExample)
EA (1) EA013692B1 (enExample)
WO (1) WO2007053650A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851620B2 (en) * 2007-06-07 2010-12-14 Board Of Regents, The University Of Texas System Methods for preparing diazonamides
US7960420B2 (en) * 2007-12-21 2011-06-14 Joyant Pharmaceuticals, Inc Diazonamide analogs with improved solubility
EP2268146B1 (en) * 2008-04-29 2015-08-26 Joyant Pharmaceuticals, Inc. Indoline anti-cancer agents
US8153619B2 (en) * 2008-05-22 2012-04-10 Joyant Pharmaceuticals, Inc. Diazonamide analogs
HUE037730T2 (hu) * 2011-04-22 2018-09-28 Joyant Pharmaceuticals Inc Diazonamid analógok
US10353032B2 (en) * 2015-10-27 2019-07-16 Halliburton Energy Services, Inc. Viscosity determination apparatus, systems, and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022720B2 (en) 2001-08-24 2006-04-04 Board Of Regents, The University Of Texas System Synthetic diazonamides as novel anti-mitotic agents
US7517895B2 (en) * 2001-08-24 2009-04-14 Board Of Regents, The University Of Texas System Synthetic diazonamides

Also Published As

Publication number Publication date
BRPI0618136A2 (pt) 2011-08-16
EP1948169A4 (en) 2009-11-04
EP1948169A2 (en) 2008-07-30
JP2009513710A (ja) 2009-04-02
EA013692B1 (ru) 2010-06-30
US20070149583A1 (en) 2007-06-28
EA200801238A1 (ru) 2008-12-30
US7538129B2 (en) 2009-05-26
WO2007053650A2 (en) 2007-05-10
WO2007053650A3 (en) 2007-11-22
AU2006308849A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
ECSP10010042A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
CU23831B1 (es) Compuestos de pirrolo-pirimidina
CL2007002234A1 (es) Compuestos derivados de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas.
CR11019A (es) 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas
PA8770101A1 (es) Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
NO20075068L (no) Lipocalinprotein
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
CR20110134A (es) Compuestos con anillos espiro-tricíclicos como moduladores de Beta-secretasas y métodos de uso
CL2007002382A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel.
UY32123A (es) Derivados de n - (sustituido) - 4 - (but-2-iniloxi) - benzamida, sus racematos, diastereòmeros, enantiòmeros y las sales de los mismos y aplicaciones
CL2008002162A1 (es) Compuestos derivados de 3-benzoisoxazol-piperidin; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento y/o prevencion de trastornos cognitivos, adiccion a drogas, depresion, ansiedad, entre otras.
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
CL2008002049A1 (es) Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
UY33276A (es) Compuestos de amino-oxazinas y amino-dihidrotiazina como moduladores de beta-secretasa y métodos de uso
CR9344S (es) Regadera
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
CR10038A (es) Analogo de la diazonamida a
HN2006037713A (es) Compuestos utiles en terapia
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos
PA8784301A1 (es) Oxazolidinonas sustituidas y su uso
CO6280510A2 (es) Pirimidil ciclopentanos hidroxilados como inhibidores de akt proteina quinasa
CR8300S (es) Recipiente para ajo
CL2011000100A1 (es) Uso de un inhibidor de desacetilasa de histona para el tratamiento de la enfermedad de hodgkin.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)